Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium lactate infusion in GLUT1 deficiency syndrome
2019-003676-39Phase 2Completed
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Sodium lactate in Glucose Transporter Type 1 Deficiency Syndrome (Glut1DS) and epilepsy. Primary endpoint: Change in frequency or form of epileptic discharges on EEG. Started Jun 2020; status: completed.
02
Drugs
Sodium lactate
03
Conditions
Glucose Transporter Type 1 Deficiency Syndrome (Glut1DS)epilepsy
Beyond the preview
Go deeper on 2019-003676-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003676-39.